Aevus Precision Diagnostics’ mission is to empower physicians and other healthcare providers by harnessing the powers of pharmacogenomics. Ultimately your genes are responsible for what prescription drugs will work best for you.
Today, nearly 1 in 10 people in the United States have been diagnosed with type 2 diabetes (T2D). With the prevalence of T2D expected to double in the next 15 years to 60 million people in the U.S. alone, choosing the correct medication is critical for improved health outcomes. Anti-diabetic medications constitute ~10% of the total prescription drugs spending in the U.S., and the disease itself plays a signiﬁcant role in our healthcare expenditure.